Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION (BSX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/18/2018 04/19/2018 04/20/2018 04/23/2018 04/24/2018 Date
28.94(c) 28.89(c) 28.84(c) 28.82(c) 28.5(c) Last
5 352 226 5 764 900 8 660 986 5 702 761 8 332 631 Volume
+0.28% -0.17% -0.17% -0.07% -1.11% Change
More quotes
Financials (USD)
Sales 2018 9 748 M
EBIT 2018 2 437 M
Net income 2018 1 375 M
Debt 2018 4 017 M
Yield 2018 -
Sales 2019 10 385 M
EBIT 2019 2 705 M
Net income 2019 1 640 M
Debt 2019 2 806 M
Yield 2019 -
P/E ratio 2018 28,41
P/E ratio 2019 24,18
EV / Sales2018 4,49x
EV / Sales2019 4,10x
Capitalization 39 757 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.The Cardiovascular segment comprises of technologies or... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
04/24BOSTON SCIENTIFIC : $30,773 Federal Contract Awarded to Boston Scientific
AQ
04/24BOSTON SCIENTIFIC : Announces Positive Late-Breaking Data From The INTREPID Stud..
PU
04/23BOSTON SCIENTIFIC : 65-- 506 - boston# 1698 - pre surgery defib procedure on 4-1..
AQ
04/20BOSTON SCIENTIFIC CORPORATION : quaterly earnings release
04/20LATEST RESEARCH ON GLOBAL DEFIBRILLA : Defibrillator Market Global Industry Anal..
AQ
04/19BOSTON SCIENTIFIC : An Application for the Trademark "MYLUX" Has Been Filed by B..
AQ
04/19BOSTON SCIENTIFIC : An Application for the Trademark "TYPHOONRFA" Has Been Filed..
AQ
04/18BOSTON SCIENTIFIC : acquires California-based women`s healthcare company, nVisio..
AQ
04/17BOSTON SCIENTIFIC : buys nVision Medical in $275M deal
AQ
04/16NEUROLOGY DEVICES MARKET TO GROW AT : Neurology Devices Market Analysis, Market..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
04/23EUROPE MARKETS : European Stocks Hit 10-week High As Rising Bond Yields Lift Fin..
DJ
04/23Siemens CEO says rail business performed well in Q2
RE
04/23ROYAL PHILIPS : Trade war worries Philips as it banks on China growth
RE
04/23ROYAL PHILIPS : Correction to Philips 1Q Earnings Story
DJ
04/23ROYAL PHILIPS : Philips sees negative effects from US-China trade war - CEO
RE
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
BOSTON SCIENTIFIC CORPORATION - 2012
All technical elements to short
SELL
More Strategies
Latest Tweets
12:26a$SVSA join fanpage 1000% run???? ?? $CGIX $CLDX $RGSE $ACIA $OSN $LPTX $ERI $.. 
12:15a$SVSA .04 join fanpage. C why my target is $1 post 2020??? $CGIX $CLDX $RGSE .. 
04/24Boston Scientific Q1 Preview: Expect MedSurg To Drive Earnings Growth: Boston.. 
04/24Upcoming conference calls $HA $MANH $SVU $TXN $WYNN $AMGN $COF $CREE $CSL $.. 
04/24Neovasc $NVCN Receiving Somewhat Favorable Press Coverage, Study Finds  
More tweets
Qtime:123
News from SeekingAlpha
04/24Notable earnings before Wednesday?s open 
04/24Boston Scientific's DBS system shows treatment effect in Parkinson's patients.. 
04/20Key events next week - healthcare 
04/16Boston Scientific acquires nVision Medical for up to $275M 
04/04VALUATION DASHBOARD : Healthcare - Update 
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 31,8 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION14.97%39 757
THERMO FISHER SCIENTIFIC12.27%86 857
DANAHER CORPORATION7.84%70 780
INTUITIVE SURGICAL22.72%51 587
ROYAL PHILIPS10.61%37 856
ILLUMINA11.95%35 894